NCT07164703View on ClinicalTrials.gov

A Real-World Study of Precision Treatment for Advanced Cholangiocarcinoma Based on Molecular Subtyping

Not yet recruitingOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

October 1, 2029

Study Completion Date

October 31, 2029

Conditions
Advanced Cholangiocarcinoma (Part 1)
Interventions
DRUG

Targeted drugs or immunotherapies for cholangiocarcinoma based on targetable gene mutations.

Targeted drugs or immunotherapies for cholangiocarcinoma based on targetable gene mutations.

Trial Locations (1)

350001

Affiliated Provincial Hospital of Fuzhou University, Fuzhou

All Listed Sponsors
lead

Mao-Lin Yan

OTHER

NCT07164703 - A Real-World Study of Precision Treatment for Advanced Cholangiocarcinoma Based on Molecular Subtyping | Biotech Hunter | Biotech Hunter